32.99.Z - Production of other products not classified elsewhere
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
23.19.Z - Manufacture of other non-metallic mineral products
23.49.Z - Manufacture of other non-metallic mineral products
71.12.Z - Engineering activities and related technical consultancy
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,1 | -0,2 | -0,2 | -16,6 |
EBITDA | -0 | -0,3 | -0,2 | 48,9 |
Short time liabilities | 0,5 | 0,7 | 0,7 | 11,4 |
Income tax | 0 | |||
Equity capital | -1,9 | -2,1 | -2,3 | -8,8 |
Operating profit (EBIT) | -0 | -0,3 | -0,2 | 48,9 |
Assets | 0,3 | 0,3 | 0,2 | -4,9 |
Net profit (loss) | -0,1 | -0,2 | -0,2 | -16,6 |
Cash | 0 | 0 | 0 | -59,2 |
Net income from sale | 0,5 | 0,4 | 0,2 | -33,4 |
Liabilities and provisions for liabilities | 2,3 | 2,4 | 2,5 | 7,4 |
Working assets | 0,3 | 0,2 | 0,2 | -5,9 |
Depreciation | 0 | 0 | 0 | 0 |
Basic operational activity income | 26,3 | |||
% | % | % | p.p. | |
Profitability of capital | 4,7 | 7,6 | 8,1 | 0,5 |
Equity capital to total assets | -588,3 | -843,6 | -965,2 | -121,6 |
Gross profit margin | -19,5 | -45,5 | -79,5 | -34 |
EBITDA Margin | -5,4 | -96,3 | -73,8 | 22,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 415 | 692 | 1157 | 465 |
Current financial liquidity indicator | 0.5379126071929932 | 0.3069142699241638 | 0.25904759764671326 | 0 |
Net dept to EBITDA | -70.55934143066406 | -5.119703769683838 | -10.630156517028809 | -5,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane